Rifampicin
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<scene name='10/1022377/Cv/2'>THERMUS AQUATICUS CORE RNA POLYMERASE-RIFAMPICIN COMPLEX</scene> ([[1i6v]]). | <scene name='10/1022377/Cv/2'>THERMUS AQUATICUS CORE RNA POLYMERASE-RIFAMPICIN COMPLEX</scene> ([[1i6v]]). | ||
| + | |||
| + | <scene name='10/1022377/Cv/3'>Rifampicin binding site</scene>. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 13:58, 4 January 2024
| |||||||||||
References
- ↑ 1.0 1.1 "Rifampin". The American Society of Health-System Pharmacists. Archived from the original on 2015-09-07. Retrieved Aug 1, 2015.
- ↑ Sterling TR, Njie G, Zenner D, Cohn DL, Reves R, Ahmed A, Menzies D, Horsburgh CR Jr, Crane CM, Burgos M, LoBue P, Winston CA, Belknap R. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep. 2020 Feb 14;69(1):1-11. PMID:32053584 doi:10.15585/mmwr.rr6901a1
